ADX-2191

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	1

90. 網膜色素変性症

臨床試験数 : 147 / 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05392179 (ClinicalTrials.gov)	July 14, 2022	28/3/2022	A Study in Subjects With Retinitis Pigmentosa	An Open-label, Phase II Study of ADX-2191 in Subjects With Retinitis Pigmentosa	Retinitis Pigmentosa	Drug: ADX-2191	Aldeyra Therapeutics, Inc.	NULL	Recruiting	18 Years	N/A	All	8	Phase 2	United States